Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Integration and usability of a digital cancer risk stratification tool to optimize identification of patients at risk for hereditary cancers: A pilot study.

Gynecologic oncology - 1 Apr 2024

Webster Emily M, Perez Luiza, Ahsan Muhammad Danyal, Levi Sarah, Chandler Isabelle, Thomas Charlene, Babagbemi Kemi, Sharaf Ravi N, Frey Melissa K

Abstract excerpt

BACKGROUND: Patients with a personal or family history of cancer may have elevated risk of developing future cancers, which often remains unrecognized due to lapses in screening. This pilot study assessed the usability and clinical outcomes of a cancer risk stratification tool in a gynecologic oncology clinic. METHODS: New gynecologic oncology patients were prompted to complete a commercially developed personal...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Breast Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Predisposition to Disease

Share to Genetic Testing

Share to Pilot Projects

Share to Risk Assessment

Source

Identifiers

PMID: 38460222
DOI: 10.1016/j.ygyno.2024.02.028

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Integration and usability of a digital cancer risk stratification tool to optimize identification of patients at risk for hereditary cancers: A pilot study.PMID 38460222Read ↗

Validation of a guidelines-based digital tool to assess the need for germline cancer genetic testingSemantic proximity Read ↗

Protocol for Health Risk Information Technology-Assisted Genetic Evaluation (HeRITAGE): a randomised controlled trial of digital genetic cancer risk assessment in a diverse underserved gynaecology clinic.Semantic proximity Read ↗

Online Screening and Virtual Patient Education for Hereditary Cancer Risk Assessment and Testing.Semantic proximity Read ↗

BRCA-DIRECT digital pathway for diagnostic germline genetic testing within a UK breast oncology setting: a randomised, non-inferiority trialSemantic proximity Read ↗

Communicating risk of hereditary breast and ovarian cancer with an interactive decision support tool.Semantic proximity Read ↗

A Randomized Hybrid Type I Effectiveness-Implementation Study of an eHealth Delivery Alternative for Cancer Genetic Testing for Hereditary Cancer (eREACH2): study protocolSemantic proximity Read ↗

Digital innovation for cancer risk assessment allows large-scale service redevelopment of regional cancer genetics service delivery.Semantic proximity Read ↗

Use of a web-based risk appraisal tool for assessing family history and lifestyle factors in primary care.Semantic proximity Read ↗

In search of a familial cancer risk assessment tool.Semantic proximity Read ↗

Adaptation and early implementation of the PREdiction model for gene mutations (PREMM5™) for lynch syndrome risk assessment in a diverse population.Semantic proximity Read ↗

Development of a person-centred digital platform for the long-term support of people living with an adult-onset genetic disease predisposition: a mixed-methods study protocol.Semantic proximity Read ↗

Piloting a Spanish-Language Web-Based Tool for Hereditary Cancer Genetic Testing.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.